scholarly journals Effects of Gastrectomy on Pharmacokinetic Profiles and Side Effects of Oral Etoposide in Lung Cancer Patients.

1999 ◽  
Vol 25 (4) ◽  
pp. 368-375 ◽  
Author(s):  
YORINOBU MAEDA ◽  
TOSHIO KONISHI ◽  
HIROYUKI YAMATO ◽  
KEI OMODA ◽  
TERUMASA OHUNE ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Side Effects ◽  
Cancer Patients ◽  
Oral Etoposide ◽  
Lung Cancer Patients ◽  
Pharmacokinetic Profiles

Cutaneous Side Effects in 19 Lung Cancer Patients Treated with Gefitinib (Iressa)

2004 ◽  
Vol 66 (6) ◽  
pp. 602-607 ◽  
Author(s):  
Miho UCHIHIRA ◽  
Takahiro EJIMA ◽  
Takao UCHIHIRA ◽  
Jun ARAKI ◽  
Toshiaki KAMEI
Keyword(s):  
Lung Cancer ◽  
Side Effects ◽  
Cancer Patients ◽  
Cutaneous Side Effects ◽  
Lung Cancer Patients

Using Naïve Bayes Algorithm to Estimate the Response to Drug in Lung Cancer Patients

2019 ◽  
Vol 21 (10) ◽  
pp. 734-748 ◽  
Author(s):  
Baoling Guo ◽  
Qiuxiang Zheng
Keyword(s):  
Lung Cancer ◽  
Side Effects ◽  
Cancer Patients ◽  
Drug Response ◽  
Treatment Options ◽  
Clinical Manifestations ◽  
Treatment Strategies ◽  
Cancer Resistance ◽  
Lung Cancer Patients ◽  
Bayes Algorithm

Aim and Objective: Lung cancer is a highly heterogeneous cancer, due to the significant differences in molecular levels, resulting in different clinical manifestations of lung cancer patients there is a big difference. Including disease characterization, drug response, the risk of recurrence, survival, etc. Method: Clinical patients with lung cancer do not have yet particularly effective treatment options, while patients with lung cancer resistance not only delayed the treatment cycle but also caused strong side effects. Therefore, if we can sum up the abnormalities of functional level from the molecular level, we can scientifically and effectively evaluate the patients' sensitivity to treatment and make the personalized treatment strategies to avoid the side effects caused by over-treatment and improve the prognosis. Result & Conclusion: According to the different sensitivities of lung cancer patients to drug response, this study screened out genes that were significantly associated with drug resistance. The bayes model was used to assess patient resistance.

scholarly journals P3-111: Cutaneous side–effects of erlotinib treatment in lung cancer patients

2007 ◽  
Vol 2 (8) ◽  
pp. S726
Author(s):  
Ricardo Lima ◽  
Bárbara Seabra ◽  
Nuno Menezes ◽  
Ana Moreira ◽  
Paulo Varela ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Side Effects ◽  
Cancer Patients ◽  
Cutaneous Side Effects ◽  
Lung Cancer Patients

Bioavailability of 50- and 75-mg oral etoposide in lung cancer patients

1996 ◽  
Vol 37 (4) ◽  
pp. 327-331 ◽  
Author(s):  
Y. Fujiwara ◽  
Terumasa Ohune ◽  
K. Okusaki ◽  
Kenji Niitani ◽  
Hidetaka Sumiyoshi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Cancer Patients ◽  
Oral Etoposide ◽  
Lung Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document